Form 8-K - Current report:
SEC Accession No. 0001628280-26-013552
Filing Date
2026-03-03
Accepted
2026-03-03 07:03:05
Documents
40
Period of Report
2026-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K espr-20260302.htm   iXBRL 8-K 39704
2 EX-2.1 exhibit21.htm EX-2.1 1103830
3 EX-99.1 a991pressrelease.htm EX-99.1 26525
4 EX-99.2 a992investorpresentation.htm EX-99.2 7840
8 esperiontherapeuticsstrate.jpg GRAPHIC 245100
9 esperiontherapeuticsstratea.jpg GRAPHIC 242791
10 esperiontherapeuticsstrateb.jpg GRAPHIC 227477
11 esperiontherapeuticsstratec.jpg GRAPHIC 301833
12 esperiontherapeuticsstrated.jpg GRAPHIC 266772
13 esperiontherapeuticsstratee.jpg GRAPHIC 95683
14 esperiontherapeuticsstratef.jpg GRAPHIC 202371
15 esperiontherapeuticsstrateg.jpg GRAPHIC 87581
16 esperiontherapeuticsstrateh.jpg GRAPHIC 272961
17 esperiontherapeuticsstratei.jpg GRAPHIC 243620
18 esperiontherapeuticsstratej.jpg GRAPHIC 100221
19 esperiontherapeuticsstratek.jpg GRAPHIC 309538
20 esperiontherapeuticsstratel.jpg GRAPHIC 213639
21 esperiontherapeuticsstratem.jpg GRAPHIC 476053
22 esperiontherapeuticsstraten.jpg GRAPHIC 195514
23 esperiontherapeuticsstrateo.jpg GRAPHIC 281533
24 esperiontherapeuticsstratep.jpg GRAPHIC 414316
25 esperiontherapeuticsstrateq.jpg GRAPHIC 251559
26 esperiontherapeuticsstrater.jpg GRAPHIC 99745
27 esperiontherapeuticsstrates.jpg GRAPHIC 264074
28 esperiontherapeuticsstratet.jpg GRAPHIC 382831
29 esperiontherapeuticsstrateu.jpg GRAPHIC 283309
30 esperiontherapeuticsstratev.jpg GRAPHIC 241349
31 esperiontherapeuticsstratew.jpg GRAPHIC 316921
32 esperiontherapeuticsstratex.jpg GRAPHIC 314606
  Complete submission text file 0001628280-26-013552.txt   10224869

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20260302.xsd EX-101.SCH 1798
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20260302_lab.xml EX-101.LAB 22548
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20260302_pre.xml EX-101.PRE 13060
42 EXTRACTED XBRL INSTANCE DOCUMENT espr-20260302_htm.xml XML 2835
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 26711002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)